PolyPEPI1018
spdr s&p biotech,ishares biotechnology,Treos bio
['rectal', 'colorectal', '$ibb', '$xbi']
treos bio presents final results from a phase 1b study of polypepi1018 immunotherapy for late-stage metastatic colorectal cancer at the 2023 american society of clinical oncology (asco) annual meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt